Clinical Trial Update: The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines [Phase 1, Phase 2]

View source ↗

Summary

A completed clinical trial update for PROTOXIN evaluating safety and efficacy in subjects with moderate to severe glabellar lines across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Protoxin

Snippet

Sponsor: Protox Inc. | Conditions: Glabellar Frown Lines | Phase 1, Phase 2 | Status: COMPLETED